Mateo Lendoire de Undurraga
Appearances
DateMay 21, 2024INTRODUCTION: Pathologic response after preoperative chemotherapy has been associated with overall survival, and RAS mutational status could stratify patients with minor pathologic response (>50%)…Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center- DateMay 21, 2024Background: Surgeons may consider parenchymal-sparing (PSH) or one-stage major hepatectomy (MH) for patients with bilateral colorectal liver metastases (CLM). However, outcomes of these two approaches for patients with advanced bilateral disease are underreported…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center 
DateMay 18, 2024RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCERModerators
Stony Brook University HospitalCleveland ClinicUniversity of Wisconsin-MadisonUniversity of Alabama at Birmingham (UAB)Speakers
Massachusetts General Hospital
